Antigen preparations. To prepare EBV VCA, the cell suspension from one bottle of P3HR1 cells was centrifuged at 1,000 rpm for 10 min, and the cell pellet was reconstituted in 0.5 ml of phosphate-buffered saline (PBS) (0.15 M, pH 7.4). Drops of cell suspension were applied to a slide; in each spot the cell density was checked microscopically, and the concentration was adjusted, if necessary, to give an almost confluent cell smear. The slides were air dried, fixed in acetone at 4°C for 15 min, and then stored at -20°C. A reference serum (MLZ 78 
Epstein-Barr virus (EBV) is an agent with a worldwide distribution. The primary infection in vivo is associated with several responses ranging from asymptomatic seroconversion to infectious mononucleosis. Moreover, EBV is implicated in the pathogenesis of at least two htman malignancies, Burkitt lymphoma and nasopharingeal carcinoma. After primary infection the virus establishes a latent, persistent infection among B lymphocytes (11) . Carriers of the virus may periodically develop a reactivation as indicated by viral excretion and immunological response. In some conditions, such as immunostippression, malignancy, and pregnancy (1, 5), the reactivated infections are particularly frequent. The evidence of active EBV infections is based usually on the elevations of the immune response to EB viral antigens in the patients.
Serological testing for antibodies to EBV is done routinely in diagnostic laboratories and provides useful information regarding immune status and active EBV infection. Several methodologies are available for the diagnosis of EBV infection, including the test for heterophil antibodies of the Paul Bunnel type, enzyme-linked immunosorbent assays (10), and immunoadherence hemagglutination (7). The indirect immunofluorescence (IF) assay, however, is currently the method most widely used to detect antibodies of different classes against EBV-induced antigens (2).
In recent years, immunoenzymatic staining has been employed as a valid alternative to IF techniques in virological studies. Up to now, the immunoperoxidase technique has been the immunoenzymatic method of choice for the detection and quantitation of viral antibody (3, 4), but the effectiveness of this method can be impaired by the endogenous peroxidase activity commonly found in several mammalian cells.
Alkaline phosphatase has also been applied in enzymelabeled antibody studies, both in immunohistological methods (9) and in enzyme-linked immunosorbent assay techniques (8). Our study therefore aimed to explore the use of an alkaline phosphatase immunocytochemical staining in the detection of ahtibodies against EBV-induced viral capsid antigens (VCA) and EBV early antigens (EA). We compared the antibody response to EBV-induced VCA and EA, visu-MATERIALS AND METHODS Cells. P3HR1 and Raji lymphoblastoid cell lines were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum in the presence of 10 U of penicillin and 50 ,ug of streptomycin per ml. Cells were passaged routinely twice a week. To assess cell viability, P3HR1 and Raji cells were stained with trypan blue (12).
Antigen preparations. To prepare EBV VCA, the cell suspension from one bottle of P3HR1 cells was centrifuged at 1,000 rpm for 10 min, and the cell pellet was reconstituted in 0.5 ml of phosphate-buffered saline (PBS) (0.15 M, pH 7.4). Drops of cell suspension were applied to a slide; in each spot the cell density was checked microscopically, and the concentration was adjusted, if necessary, to give an almost confluent cell smear. The slides were air dried, fixed in acetone at 4°C for 15 min, and then stored at -20°C. A reference serum (MLZ 78 To assess the reproducibility of the IAPhA, 10 sera were selected; 8 sera had anti-VCA IF titers ranging from 1/40 to 1/2,560 and 2 had anti VCA titers less than 1/10. Six replicate samples of each of these sera were tested on different assays to confirm reproducibility. In all 10 sera retested, differences in titers were less than or equal to twofold, and 98% of the observations were within one dilution of the expected antibody value.
Antibodies to EA. The IF assay for EBV-induced EA showed that, of the 91 sera examined, 34 had titers less than 1/10 and 57 proved positive with titers ranging from 1/10 to 1/320. With IAPhA, 36 samples had titers less than 1/10 and 55 were positive with titers ranging from 1/10 to 1/320. Of all the 91 serum samples examined, 87 were either positive (54 serum samples) or negative (33 serum samples) by both procedures. The distribution of values of antibody against EBV EA demonstrated by IF and IAPhA is shown in Fig. 3 . For the total 91 serum samples examined for antibody against EA, the coefficient of correlation was 0.94, whereas for the 54 samples positive at both assays the coefficient of correlation was 0.90. The reproducibility of the results obtained for antibody against EA by IAPhA was determined in 10 sera as described above for VCA, and the differences in titers were less than or equal to twofold; 97.4% of the observations were within the expected antibody value. To test the specificity of IAPhA, cell smears prepared for VCA and EA were stained by IAPhA with reference human sera negative for EBV-induced antigens; these cell preparations proved uniformly colorless and unstained. Moreover two 
